Guidelines for the Management of Spontaneous Intracerebral HemorrhageLewis B. Morgenstern, Rafael J. Tamargo, J. Claude Hemphill et al.|Stroke|2010Cited by 1.5k
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Lydia D. Foster et al.|The Lancet Neurology|2019Cited by 249
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale–Associated StrokeAkram Y. Elgendy, Jonathan M. Tobis, Jeffrey L. Saver et al.|JAMA Neurology|2020Cited by 205
Time to Anticoagulation Reversal and Outcomes After Intracerebral HemorrhageKevin N. Sheth, Jeffrey L. Saver, Raymond Chuen‐Chung Chang et al.|JAMA Neurology|2024Cited by 81